“…DspB in combination with Triclosan is now marketed in gel preparations for the treatment of wound and skin infections and for disinfection of medical devices, suggesting that combinations of antimicrobials and EPS-degrading enzymes can represent a powerful tool for biofilm eradication in these settings (Donelli, Francolini et al, 2007;Eckhart, Fischer, Barken, Tolker-Nielsen, & Tschachler, 2007 (Gawande, Leung, & Madhyastha, 2014). Finally, a combination of triclosan and DspB showed synergistic anti-biofilm activity against S. aureus, S. epidermidis , and E. coli (Darouiche, Mansouri, Gawande, & Madhyastha, 2009 (Banat, Franzetti et al, 2010;Díaz De Rienzo, Stevenson, Marchant, & Banat, 2015;Makkar & Rockne, 2003, Md, 2012Padmavathi & Pandian, 2014). The high antimicrobial, antiadhesive and strong dispersal properties of BSs make them hopeful agents for eradicating biofilms (some BSs that inhibit biofilm formation are listed in Table 3) (Krasowska, 2010 (Hassan & Mohammad, 2015) Acinetobacter indicus NS NS Treatment of biofilms for seven days at 500 μg/ml resulted in up to 82.5% biofilm disruption (Karlapudi et al, 2018) B. subtilis Lipopeptide surfactin, iturin and fengycin Biofilm formation on uropathogenic bacteria reduced (Moryl, Spętana et al, 2015) Corynebacterium xerosis Lipopeptide Coryxin Disrupted preformed biofilms of E. coli (66%), S. mutans (80%), S. aureus (82.5%), and P. aeruginosa (30%).…”